Improving communication to increase HPV vaccination among adolescents
IMPACT Project 3 – Engaging clinical champions to improve HPV vaccine communication and uptake in healthcare systems
['FUNDING_P01'] · UNIV OF NORTH CAROLINA CHAPEL HILL · NIH-10926964
This study is all about helping doctors and nurses talk to teens about getting the HPV vaccine by training them in a friendly way, so more young people can get protected against HPV.
Quick facts
| Phase | ['FUNDING_P01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIV OF NORTH CAROLINA CHAPEL HILL (nih funded) |
| Locations | 1 site (CHAPEL HILL, UNITED STATES) |
| Trial ID | NIH-10926964 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the uptake of the HPV vaccine among adolescents by training healthcare providers through a program called Announcement Approach Training (AAT). The AAT is a one-hour workshop designed to equip primary care teams with effective communication strategies to recommend the HPV vaccine more frequently and effectively. By engaging clinical champions within healthcare systems, the project aims to implement AAT on a larger scale, ensuring that more adolescents receive the vaccine. The research involves collaboration with multiple healthcare systems to identify barriers and facilitators to effective vaccine communication.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents who are eligible for the HPV vaccine and their families seeking vaccination.
Not a fit: Patients who are not eligible for the HPV vaccine, such as those outside the recommended age range or with contraindications, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase HPV vaccination rates among adolescents, leading to a reduction in HPV-related cancers.
How similar studies have performed: Previous research has shown that similar communication training programs can effectively increase vaccination rates, indicating a promising approach.
Where this research is happening
CHAPEL HILL, UNITED STATES
- UNIV OF NORTH CAROLINA CHAPEL HILL — CHAPEL HILL, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GILKEY, MELISSA B — UNIV OF NORTH CAROLINA CHAPEL HILL
- Study coordinator: GILKEY, MELISSA B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.